A Lead or Senior Scientist opportunity with the Tsai Lab to develop a therapeutic platform for in vivo base editing treatments and drug products to treat patients with bone marrow failure disorders at St. Jude. Help us build an individualized therapeutic base editing platform to treat St. Jude patients with rare bone marrow failure disorders by correcting their disease-causing mutations in their hematopoietic stem cells in vivo. Dr. Tsai leads the recently launched DRIVE project (Delivering Rare-disease In vivo Editors), funding a multi-institutional, public-private partnership to develop in vivo base editors for treatment of bone marrow failure disorders. Bring your expertise in genome editing drug development to a Lead Scientist role in the Tsai Lab, where you will help advance genome editing technologies toward individualized treatments for pediatric patients. Our goal is to develop in vivo base editing drug products, complete IND-enabling studies, and open clinical trials in the next 3 years. We are seeking an outstanding and highly motivated Lead Scientist or Senior Scientist to help lead efforts to develop personalized genome editing treatments. We care deeply about the success of our scientists, and this is a unique opportunity to help lead development of an in vivo gene therapeutic gene editing platform and drug products at St. Jude, with substantial room for career growth and advancement.
Stand Out From the Crowd
Upload your resume and get instant feedback on how well it matches this job.
Job Type
Full-time
Career Level
Senior
Education Level
Ph.D. or professional degree